Search company, investor...

Founded Year

2009

Stage

Private Equity | Alive

Total Raised

$300M

Valuation

$0000 

Last Raised

$300M | 2 yrs ago

About Equashield

Equashield is a medical device company that specializes in the development and provision of Closed System Transfer Devices (CSTDs). The company's main offerings include a range of products designed for the safe handling of hazardous drugs, from the compounding process in pharmacies to administration in nursing settings. These products, which include closed syringes, adapters, connectors, and tubing sets, aim to protect healthcare workers from exposure to hazardous drugs and vapors. It was founded in 2009 and is based in Port Washington, New York.

Headquarters Location

2 Harbor Park Drive

Port Washington, New York, 11050,

United States

516-684-8200

Loading...

Loading...

Expert Collections containing Equashield

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Equashield is included in 1 Expert Collection, including Unicorns- Billion Dollar Startups.

U

Unicorns- Billion Dollar Startups

1,244 items

Equashield Patents

Equashield has filed 36 patents.

The 3 most popular patent topics include:

  • fluid dynamics
  • robotic manipulators
  • surgery
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/15/2018

9/10/2024

Computer connectors, Audiovisual connectors, Analog video connectors, Electrical signal connectors, DC power connectors

Grant

Application Date

11/15/2018

Grant Date

9/10/2024

Title

Related Topics

Computer connectors, Audiovisual connectors, Analog video connectors, Electrical signal connectors, DC power connectors

Status

Grant

Latest Equashield News

Syringes, needles and urinary catheters market in Taiwan: market size trends

Sep 19, 2024

was Becton Dickinson and Co followed by Coloplast , Stryker , Medline Industries , Cardinal Health , Novo Nordisk , Equashield and Teleflex . Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments. A Syringe is a tube-like device used to intake and expel liquid. A Needle is a slender, pointed medical instrument that is used to inject or remove biological fluids as well as to suture wounds. A Urinary Catheter is a thin piece of flexible tubing that is used to collect urine from a patient into a drainage bag. See Also: The syringes, needles and urinary catheters market in Taiwan can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice. For the latest analysis of the market size syringes, needles and urinary catheters in Taiwan, buy the report here. Sign up for our daily news round-up! Give your business an edge with our leading industry insights.

Equashield Frequently Asked Questions (FAQ)

  • When was Equashield founded?

    Equashield was founded in 2009.

  • Where is Equashield's headquarters?

    Equashield's headquarters is located at 2 Harbor Park Drive, Port Washington.

  • What is Equashield's latest funding round?

    Equashield's latest funding round is Private Equity.

  • How much did Equashield raise?

    Equashield raised a total of $300M.

  • Who are the investors of Equashield?

    Investors of Equashield include Nordic Capital.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.